Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,116.77
(
-0.31%
)
US TECH 100
26,319.20
(
0.07%
)
Dow Jones
48,838.89
(
-0.62%
)
Brent Oil
110.75
(
6.07%
)
Bitcoin
75,880.54
(
-0.61%
)
News Focus
News Focus
Post# of 257465
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 843
Posts 122903
Boards Moderated 9
Alias Born 09/05/2002

DewDiligence

Member Level

Re: vinmantoo post# 248233

Thursday, 11/13/2025 11:24:26 AM

Thursday, November 13, 2025 11:24:26 AM

Post# of 257465
DAWN acquires MRSN for $25.00/sh cash +CVR—a 182% premium to yesterday’s closing price (excluding the CVR):

https://www.globenewswire.com/news-release/2025/11/13/3187105/0/en/Day-One-Biopharmaceuticals-to-Acquire-Mersana-Therapeutics.html

The nominal deal value (excluding the CVR) is $129M. This acquisition is essentially a takeunder insofar as MRSN once had an enterprise value of about $3B.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today